Novartis AG (NVSEF)
162.12
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Novartis Price to Book Value : 8.224 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 8.224 |
| November 12, 2026 | 8.224 |
| November 11, 2026 | 8.224 |
| November 10, 2026 | 8.15 |
| November 09, 2026 | 8.166 |
| November 06, 2026 | 8.166 |
| November 05, 2026 | 8.128 |
| November 04, 2026 | 8.153 |
| November 03, 2026 | 8.049 |
| November 02, 2026 | 7.988 |
| October 30, 2026 | 8.135 |
| October 29, 2026 | 8.135 |
| October 28, 2026 | 8.117 |
| October 27, 2026 | 7.616 |
| October 26, 2026 | 7.616 |
| October 23, 2026 | 7.600 |
| October 22, 2026 | 7.416 |
| October 21, 2026 | 7.416 |
| October 20, 2026 | 7.430 |
| October 19, 2026 | 7.430 |
| October 16, 2026 | 7.300 |
| October 15, 2026 | 7.322 |
| October 14, 2026 | 6.991 |
| October 13, 2026 | 6.991 |
| October 12, 2026 | 7.264 |
| Date | Value |
|---|---|
| October 09, 2026 | 7.102 |
| October 08, 2026 | 6.887 |
| October 07, 2026 | 6.809 |
| October 06, 2026 | 6.809 |
| October 05, 2026 | 6.825 |
| October 02, 2026 | 6.808 |
| October 01, 2026 | 7.150 |
| September 30, 2026 | 7.150 |
| September 29, 2026 | 6.387 |
| September 28, 2026 | 6.434 |
| September 25, 2026 | 6.211 |
| September 24, 2026 | 6.280 |
| September 23, 2026 | 6.098 |
| September 22, 2026 | 6.098 |
| September 21, 2026 | 6.092 |
| September 18, 2026 | 5.892 |
| September 17, 2026 | 6.26 |
| September 16, 2026 | 6.26 |
| September 15, 2026 | 6.26 |
| September 14, 2026 | 5.938 |
| September 11, 2026 | 6.071 |
| September 10, 2026 | 6.079 |
| September 09, 2026 | 6.103 |
| September 08, 2026 | 7.238 |
| September 04, 2026 | 7.238 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 1.826 |
| Oculis Holding AG | 1.892 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Price to Book Value Related Metrics
| PE Ratio | 30.98 |
| PS Ratio | 5.609 |
| Price to Free Cash Flow | 22.80 |
| Price | 162.12 |
| Earnings Yield | 3.23% |
| Market Cap | 306.18B |
| Operating PE Ratio | 18.40 |
| Normalized PE Ratio | 24.64 |